Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

CVS Health Corp (NY: CVS )

58.35 +0.79 (+1.37%)
Streaming Delayed Price Updated: 3:58 PM EDT, Aug 16, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CVS Health Corp

< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
44 45 Next >
3 Reasons to Buy CVS Health Stock Right Now
The stock is looking sick right now, but that won't last forever. 
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
7 Top Healthcare Stocks That Pay Dividends
With uncertainty being the dominant theme of the moment, investors should consider healthcare stocks that pay dividends. 
Via InvestorPlace
The 3 Top Value Stocks to Watch in Q4 2023
Embrace financial growth with top value stocks. Get comprehensive insights and make informed decisions for a prosperous investment journey. 
Via InvestorPlace
Big Pharma's Weight Loss Drugs Vs. Snacking Industry: Who Will Prevail?
The rising prevalence of obesity and diabetes drugs like Novo Nordisk A/S's (NYSE: NVO) Wegovy and Ozempic is triggering concerns among investors about the future of the snacking industry.  
Via Benzinga
Looking At CVS Health's Recent Unusual Options Activity
Via Benzinga
Looking Into CVS Health's Recent Short Interest
Via Benzinga
Expert Ratings for CVS Health
Via Benzinga
Walgreens Ends Partnership with Microsoft-Backed Cooler Screens Amidst Technical Failures
A partnership gone sour marks the end of a technological endeavor between Walgreens Boots Alliance Inc (NASDAQ: WBA) and Cooler Screens, a vendor specializing in digital advertising screens.  
Via Benzinga
2 Exceptional Dividend Stocks to Buy in October and Hold Forever
Temporary challenges are creating bargain opportunities for investors with a long-term mindset. 
Via The Motley Fool
Here's the Michael Burry Stock That Could Be the Biggest Winner Over the Next 5 Years
The "Big Short" investor just might be a big winner with this stock. 
Via The Motley Fool
Pharmacy Retailer Giant Walgreens Considers Former Cigna Exec For CEO Role
Walgreens Boots Alliance Inc. (NASDAQ: WBA) is reportedly considering appointing Tim Wentworth, a former executive at Cigna Group (NYSE: CI), as its next CEO amid a search for leadership 
Via Benzinga
Some Economics Of Pharmacy Benefit Managers
It is a common belief, that if you could just “cut out the middleman” and “pass the savings along to consumers,” everyone would be better off. Pharmacy benefit managers are quintessential middlemen. 
Via Talk Markets
CVS Health Corp. (NYSE: CVS) Highlighted for Surprising Price Action
Via Investor Brand Network
CVS Health Unusual Options Activity For September 19
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
3 Retail Stocks to Sell Before the Damage Is Done
Macy's, Best Buy and Walgreens Boots Alliance are three retail stocks to sell in 2023 before the damage is done. 
Via InvestorPlace
Cramer Shrugs Off Stock With Over 10% Yield: 'I Don't Want That Dividend, I Need Growth'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Solaris Oilfield Infrastructure, Inc. 
Via Benzinga
Can Undervalued Healthcare Stocks Add Yield To Your Portfolio?
Health insurers UnitedHealth, Humana, and Elevance pay steady dividends, offering stability even as the industry faces headwinds regarding Medicaid coverage. 
Via MarketBeat
Global Consulting Firm McKinsey To Pay $230M In Opioid Lawsuit Settlements With US Local Governments
Consulting firm McKinsey & Company has reached a substantial settlement agreement of $230 million to resolve lawsuits filed by numerous U.S. 
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
Tuesday's Market Minute: Previewing Costco (COST) Earnings
Costco (NASDAQ: COST) reports its fourth quarter of 2023 after the bell today. Zacks expects the company to report EPS of $4.72 on revenue of $78.56 billion. The stock has had a strong year thus far,... 
Via Benzinga
3 Best Stocks to Buy in September and Hold Forever
Healthcare blue chip stocks with proven track records can be excellent long-term investments. 
Via The Motley Fool
CVS Health vs. Walgreens Boots Alliance: Which Is the Better Dividend Stock to Own?
Should you go with the high yield or the more conservative, lower payout? 
Via The Motley Fool
Updated Covid Vaccine US Rollout Hit by Insurance Coverage Delays - What It Means?
As the U.S. 
Via Benzinga
Exposures COVID-19
CVS Health Gains Momentum: Analyst Points To Potential 4-Star Medicare Rating
Shares of CVS Health Corp (NYSE: CVS) were trading higher on Tuesday, after attracting short interest earlier in the month. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 19, 2023
Via Benzinga
Dell Technologies To Rally More Than 15%? Here Are 10 Other Analyst Forecasts For Tuesday
Raymond James increased the price target for Vital Energy, Inc. (NYSE: VTLE) from $54 to $67. Raymond James analyst John Freeman maintained an Outperform rating. Vital Energy shares rose 0.5% to $54.37... 
Via Benzinga
2 Beaten-Down Dividend Growth Stocks That Look Like Bargains Now
Buying these dividend growers on the dips could lead to huge passive income streams by the time you're ready to retire. 
Via The Motley Fool
3 Stocks That Could Be Kicked Out of the Dow -- and the Companies That May Replace Them
Three time-tested yet poor-performing Dow components are at risk of being removed from the index. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
Stagflationary Moves In Bonds And Oil Opens Golden Opportunity
Is there anything better than stagflationary pressures on gold prices? A weaker dollar and falling interest rates create a sweet spot for gold. 
Via Talk Markets
< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
44 45 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.